Cargando…
Engineered bacterial outer membrane vesicles encapsulating oncolytic adenoviruses enhance the efficacy of cancer virotherapy by augmenting tumor cell autophagy
Oncolytic adenovirus (Ad) infection promotes intracellular autophagy in tumors. This could kill cancer cells and contribute to Ads-mediated anticancer immunity. However, the low intratumoral content of intravenously delivered Ads could be insufficient to efficiently activate tumor over-autophagy. He...
Autores principales: | Ban, Weiyue, Sun, Mengchi, Huang, Hanwei, Huang, Wanxu, Pan, Siwei, Liu, Pengfei, Li, Bingwu, Cheng, Zhenguo, He, Zhonggui, Liu, Funan, Sun, Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10203215/ https://www.ncbi.nlm.nih.gov/pubmed/37217527 http://dx.doi.org/10.1038/s41467-023-38679-z |
Ejemplares similares
-
Emerging systemic delivery strategies of oncolytic viruses: A key step toward cancer immunotherapy
por: Ban, Weiyue, et al.
Publicado: (2022) -
ONCOLYTIC VIROTHERAPY
por: Russell, Stephen J, et al.
Publicado: (2012) -
Oncolytic adenovirus Ad657 for systemic virotherapy against prostate cancer
por: Nguyen, Tien V, et al.
Publicado: (2018) -
The Feasibility of Pressurised Intraperitoneal Aerosolised Virotherapy (PIPAV) to Administer Oncolytic Adenoviruses
por: Tate, Sophia J., et al.
Publicado: (2021) -
Mesenchymal stem cells used as carrier cells of oncolytic adenovirus results in enhanced oncolytic virotherapy
por: Mahasa, Khaphetsi Joseph, et al.
Publicado: (2020)